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SUMMARY
Irregular 24 h light/dark cycles with night-time light exposure and a low
amplitude are disruptive for sleep, mood and circadian rhythms.
Nevertheless such lighting conditions are quite common in medical care
facilities. A controlled clinical trial among 196 cardiology ward patients
(mean age 66.5  13.1 years SD) investigated how a patient room
lighting intervention affects sleep, appraisal and mood across hospital-
ization. Patients were either assigned to a standardly-lit room or to a
room with an interventional lighting system offering a dynamic 24 h light/
dark cycle with low nocturnal light exposure and 2 h of bright light
(1750 lux) during daytime. Measures included wrist actigraphy and
questionnaires assessing alertness, sleep quality, anxiety, depression
and lighting appraisal. The median length of hospitalization was 5 days
in both study arms. Subjective scores on sleep, alertness, anxiety and
depression did not differ between arms. Lighting appraisal in intervention
rooms was better as compared to standardly-lit rooms, both in patients
(P < 0.001) and staff (P < 0.005). Actigraphic sleep duration of patients
improved by 5.9 min (95% CI: 0.6–11.2; P = 0.03 intervention 9 time
effect) per hospitalization day with interventional lighting instead of
standard lighting. After 5 days of hospitalization, sleep duration in the
lighting intervention rooms increased by 29 min, or a relative 7.3%, as
compared to standardly-lit rooms. A 24 h lighting system with enhanced
daytime brightness and restricted nocturnal light exposure can improve
some aspects of appraisal and objective sleep in hospital patients. More
clinical research is needed to establish the best lighting strategy to
promote healing and wellbeing within healthcare settings.
INTRODUCTION
Impaired sleep is a known hospital stressor, and hospitalized
patients struggle to get sufﬁcient sleep at night due to factors
like discomfort, worries, noise, inappropriate light exposure
and pain (Manian and Manian, 2015; Pisani et al., 2015;
Redeker and Hedges, 2002; Volicer and Bohannon, 1975).
Sleep is an important factor to promote the wellbeing and
recovery of patients. The human sleep–wake pattern is
strongly regulated by the central circadian pacemaker
residing in the suprachiasmatic nuclei within the hypothala-
mus. This pacemaker uses light–dark information to initiate
and control the timing, alignment and stability of the
endogenous 24 h patterns in our sleep, physiology, alertness
and mood. Proper timing of the light exposure is critical:
brighter daytime light conditions are associated with better
mood and sleep quality (Ancoli-Israel et al., 2003; Boubekri
et al., 2014; Harrison, 2004; Lambert et al., 2002; Mishima
et al., 2001; Riemersma-Van Der Lek et al., 2008;
White et al., 2013), while excessive light exposure during
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the evening or night-time has an acute disruptive inﬂuence on
sleep (Czeisler, 2013; Santhi et al., 2011; White et al., 2013).
The blue-light-sensitive photoreceptor pigment melanopsin
(Lucas et al., 2014) is an important mediator for the effects of
light on our sleep–wake behaviour (Hughes et al., 2015). In
many healthcare facilities access to (blue-rich) daylight is
limited, and current standards and guidelines for lighting
systems within normal patient rooms specify horizontal
illuminance thresholds in the range of 100–300 lux (CEN,
2011; IES, 2011). Consequently, the typical daytime illumi-
nance indoors is insufﬁcient to generate the same beneﬁts as
the outdoor illuminance (2000–100 000 lux of blue-rich light)
under which we have evolved. Daytime exposure to high
illuminances, from either sunlight or a few hours of bright-light
therapy, is known to have beneﬁcial effects on clinical
parameters such as recovery, length of stay (LOS), delirium,
depression, anxiety and use of pain medication (Beauchemin
and Hays, 1998; Benedetti et al., 2001; Bernhofer et al.,
2014; Taguchi et al., 2007; Tuunainen et al., 2004; Walch
et al., 2005; Youngstedt and Kripke, 2007). Moreover, in
neonatal intensive care units cycled lighting has a favourable
inﬂuence on many outcomes as compared to 2 h dimmed
light or continuous light (Morag and Ohlsson, 2013). In
people with dementia, night-time sleep increased signiﬁcantly
after 3 weeks of exposure to either morning or all-day bright
light (Sloane et al., 2007). Moreover, a single 2-h bright-light
pulse in the morning advances the circadian rhythm (Minors
et al., 1991) and can help prevent sleep-compromising
delays of the body clock.
Cardiovascular disease continues to be a major burden for
healthcare in Europe, with close to 2500 annual hospital
discharges per 100 000 inhabitants, costing €106 billion
annually, of which 49% is for inpatient hospital care (Nichols
et al., 2012). The optimization of patient room lighting
conditions can help to alleviate this burden. Therefore, we
examined the effects of a dynamic patient room lighting cycle
on sleep, appraisal and mood during hospitalization on a
cardiology ward. Patients either stayed in control rooms with
standard lighting or in intervention rooms equipped with a
new dynamic lighting system. The light intensity and spectral
composition in the intervention rooms are automatically tuned
to generate a dynamic 24 h lighting rhythm with two late-
morning hours of bright, blue-enriched white light, and low
light exposure during evenings and at night-time. Wrist
actigraphy was used to assess total sleep duration (TSD)
and sleep-onset latency (SOL). Subjective ratings were used
to evaluate sleepiness, sleep quality, headache, eye-strain,
depression, anxiety, and lighting appraisal.
MATERIALS AND METHODS
Study design
From the 15th of December 2009 until the 15th of September
2010, 196 patients of the cardiology ward of the Maastricht
University Medical Center (MUMC) in the Netherlands
participated in the study. All study participants gave written
informed consent, and the protocol was approved by the local
Medical Ethics Committee of the Maastricht University
Medical Center. Patients were assigned to either a control
room with standard (ﬂuorescent) lighting conditions or to an
intervention room in which the ﬂuorescent general lighting
had automated gradual changes in illuminance and corre-
lated colour temperature (3000–6500 K) across the day,
offering a dynamic 24 h light/dark cycle with low nocturnal
light exposure, bright, blue-enriched white light (1750 lux,
6500 K) between 10:30 and 12:30 hours, and a 45-min post-
lunch illuminance of 100 lux (3000 K) on the bed. Details of
the lighting conditions are given in Fig. 1 and in Data S1.
The study was initiated as a fully randomized controlled
clinical trial. However, the high occupancy of the ward forced
us to abandon randomization. It appeared impossible to
secure the simultaneous availability of one empty bed in both
the intervention- and control-condition on sufﬁcient inclusion
moments. Instead, room assignments were done by regular
hospital staff, based on room availability and routinely used
hospital procedures, irrespectively of health status and fully
out of reach of the investigators. The cardiologist and the
resident-cardiologist supervising the ward determined the
discharge date of a patient. The staff were not aware of the
study assessments and acted fully independently, without
any relation to the study; neither in the preparation, nor in the
execution, nor in the analysis.
Figure 1. Schematic representation of the typical 24 h proﬁle in
general lighting within intervention rooms (solid line) and control
rooms (dashed). The y-axis gives the horizontal illuminance on the
bed, and the corresponding correlated colour temperatures (CCT)
are indicated in the ﬁgure. The grey area indicates the evening and
night-time hours with manual (de)activation of the general lighting
and reading light usage. The reading light in control rooms is
undimmable and delivers 300 lux horizontal illuminance on the bed.
Intervention rooms have a dimmable reading light, with a maximum
illuminance of 300 lux. Between 23 h and 7 h, the general lighting
within intervention rooms, when activated, delivers 50 lux on the
bed with a CCT of 3000 K. The general lighting in control rooms,
when activated, always delivers 100 lux on the bed with a CCT of
3000 K.
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Study assessments
The study probed patient expectations at intake, and made
daily assessments of actigraphic sleep, Hospital Anxiety and
Depression Scale (HADS), Karolinska Sleepiness Scale
(KSS), Headache and Eye-Strain (HES) symptoms. The
Pittsburg Sleep Quality Index (PSQI) was completed at study
intake and discharge, modifying all “During the past
month. . .” questions into “During the past days. . .”. Lighting
appraisal was probed using a seven-point Likert scale
(0 = very unsatisﬁed, 3 = neutral, 6 = very satisﬁed) to
answer “How satisﬁed are you with the lighting system in
the patient rooms?”. Table 1 and the Data S1 provide more
details about these assessments.
Analysis
Between-group differences in gender, smoking, intake in
autumn/winter, hypertension, diabetes, depression history
and discharge diagnosis were tested by means of a Chi-
squared test. A Mann–Whitney test was used to assess
between-group differences in expectation, appraisal and
LOS. An independent, two-sided Student’s t-test was used
to assess between-group differences in age, body mass
index, heart rate, blood pressure and PSQI. The multilevel
regression model is described by Eq. (1).
Outcomeij ¼ b0 þ b1HospitalDayij þ b2Interventionj
þ b3ðInterventionHospitalDayÞij þ aj þ eij (1)
The time axis is represented by HospitalDayij, which
indicates the number of days a patient (j) has spent at the
hospital at any moment (i, expressed in days) that the
Outcomeij is measured. On the hospital intake day, Hospi-
talDay equals one. The parameter Interventionj indicates the
lighting condition of a given patient j. It equals 0 for control
patients and 1 for intervention patients. The intercept of the
model represents the Outcome parameter at baseline (i.e. for
HospitalDay = 0, this is the last night before hospitalization),
and is deﬁned b0 and b2. Within control patients the time
dependency of Outcomeij is described by b1, and in
intervention patients by b1 + b3, where b3 represents the
intervention 9 time interaction. In Eq. (1), aj represents the
patient-dependent (random) part of the intercept, and ɛij
represents the error term.
The model parameters were assessed for two cases. The
ﬁrst case used all available data. The second case only used
the data collected during the ﬁrst 5 days (and 5 nights) of the
hospitalization period (i.e. HospitalDay ≤ 5). This allows to
evaluate the robustness of the model and its effect sizes
when the follow-up time is restricted to the median LOS of
5 days. Simultaneously, it provides extra information on how
the effect-estimates develop over time. Regression coefﬁ-
cients were tested for signiﬁcance (P < 0.05) with the Wald
test. The P-values are two-tailed.
RESULTS
In total, 580 cardiology ward patients were considered for
inclusion in the study. At study closure 196 participants
(mean age 66.5  13.1 years SD) were enrolled (Fig. 2).
Table 2 provides more information on the characteristics of
the study participants. Two intervention patients discontinued
their participation: one due to migraine complaints induced by
the interventional lighting; and one due to actiwatch-induced
skin irritation. No patient dropped out of the study due to
death. The analyses were done within a homogeneous
patient population, excluding all patients for which the
discharge diagnosis differed from coronary artery disease
or heart failure and those patients that only stayed for one
night. More details on the characteristics of the various sub-
samples within this study are provided in the Data S2.
At study intake, patient expectations regarding effects of
the lighting system on visual comfort, mood, performance,
alertness, vitality, concentration and sleep quality did not dif-
fer between control and intervention patients (P > 0.14).
Length of stay
The median LOS [ interquartile range (IQR)] was 4.5
( 3) days in control patients and 5 ( 5) days in interven-
tion patients, without a between-group difference (z = 0.23,
P = 0.82). The largest LOS was 19 days.
Lighting appraisal
Scores on satisfaction with the lighting were analysed for 90
patients and 36 nursing-staff members. Median satisfaction
Table 1 Study assessments, and their timing and analysis
Assessment Timing of assessment Statistical analysis
Expectations Patient intake Mann–Whitney test
Lighting
appraisal*
Patient discharge Mann–Whitney test
LOS Hospital discharge Mann–Whitney test
PSQI Patient intake and
discharge
Independent Student’s
t-test
Actigraphic
sleep
Daily Multilevel regression
HADS Daily at 13:00 hours Multilevel regression
KSS Daily at 09:00, 11:00,
13:00 and 15:00 hours
Multilevel regression
HES Daily at 11:00 hours Multilevel regression
Multilevel linear regression analyses were performed with MLwiN
software (MLwiN 2.23; Centre for Multilevel Modeling, Institute of
Education, London, UK) and with Stata (StataCorp, 2013).
HADS, Hospital Anxiety and Depression Scale; HES, Headache
and Eye-Strain questionnaire; KSS, Karolinska Sleepiness Scale;
LOS, length of stay; PSQI, Pittsburgh Sleep Quality Index.
*This questionnaire was also used in staff: once before and once
after the installation of the lighting intervention.
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Assessed for eligibility    580 
Excluded     384 
•  Declined to participate  (n = 384) 
Excluded from analysis  
•  discharge diagnosis  
other than HF or CAD  (n = 12) 
Included in analysis   48 
Lost to follow-up  
•  moved elsewhere/to other ward  (n = 11) 
•  moved to other room   (n = 3) 
•  discharge within two days (n = 13) 
•  unknown   (n = 1) 
 
 
Discontinued participation 
•  withdrew    (n = 10)  
•  migraine    (n = 1) 
•  skin irritation    (n = 1) 
Total lost in follow-up    40 
Allocated to intervention   100 
•  received allocated intervention  (n = 100)
Lost to follow-up 
•  moved elsewhere/to other ward  (n = 9) 
•  moved to other room   (n = 2) 
•  discharge within two days  (n = 9) 
•  unknown     (n = 1) 
•  still hospitalised at end of study (n = 1) 
 
Discontinued participation 
•  withdrew     (n = 17) 
  
 
 
Total lost in follow-up    39 
Allocated to control    96 
•  received allocated intervention  (n = 96)
Included  196 
Included in LOS 
analysis  47 
•  Missing  data for  
LOS             (n = 1) 
Excluded from analysis  
•  discharge diagnosis  
other than HF or CAD  (n = 13) 
Included in analysis   44 
Included in PSQI 
analysis  43 
•  Missing  data for  
PSQI           (n = 5) 
Included in LOS 
analysis  44 
•  Missing  data for  
LOS             (n = 0) 
Included in PSQI 
analysis  37 
•  Missing  data for  
PSQI           (n = 7) 
Figure 2. Flow of participants included in the study.
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( IQR) was 5 ( 2) and 5 ( 1) for control and intervention
patients, respectively. Intervention patients were signiﬁcantly
more satisﬁed with their lighting as compared to control
patients (z = 4.4, P < 0.001). Upon installation of the new
lighting, the median staff satisfaction with the lighting
improved from 3.0 ( 2) to 3.5 ( 1). Staff satisfaction for
the new lighting was signiﬁcantly better (z = 3.0,
P < 0.005).
Subjective sleep: PSQI scores
The global PSQI scores at intake and discharge are given in
Table 3, along with the within-subject discharge minus intake
score (delta) for both groups. There were no signiﬁcant
differences between the groups. However, subjective sleep,
as judged from the delta global PSQI value, tended to
improve within intervention rooms. The detailed PSQI results
are presented in the Data S2.
Multilevel linear regression analyses
We evaluated several regression model extensions of
Eq. (1), including a random intercept on the room level and
random slopes (see Data S2). In each case where Eq. (1)
yielded a signiﬁcant interventional effect, we concluded that
Eq. (1) provides a reasonable model for the interventional
effect estimation, obviating the need for these extensions.
Objective sleep: actigraphy
Table 4 summarizes the regression results for actigraphic
TSD and SOL. Figure 3 displays the raw TSD data and
regression lines for the individual control- and intervention-
patients. Therewere no signiﬁcant interventional effects on the
baseline effect estimates (b2) of the regression models in
Table 4. The TSD data yielded a signiﬁcant interaction effect
(b3) between HospitalDay and the intervention in the 20-day
Table 2 Characteristics of the study intake population in the control and intervention groups
Intervention group (n = 100) Control group (n = 96) P-value
Age (years), mean  SD 68.1  12.2 (n = 100) 64.9  13.9 (n = 96) 0.09
Female 34 (n = 100) 27 (n = 96) 0.38
Body mass index (kg m2), mean  SD 27.6  5.5 (n = 98) 27.5  5.6 (n = 95) 0.95
Heart rate (bpm), mean  SD 75.5  16.2 (n = 58) 79.3  26.2 (n = 56) 0.36
Blood pressure diastolic (mmHg), mean  SD 75.6  12.5 (n = 80) 72.6  14.0 (n = 82) 0.14
Blood pressure systolic (mmHg), mean  SD 129.9  18.9 (n = 80) 122.3  18.1 (n = 82) 0.01
Active smoking 11 (n = 98) 20 (n = 92) 0.05
Diabetes 28 (n = 96) 17 (n = 91) 0.09
Hypertension 46 (n = 95) 43 (n = 94) 0.71
Depression history 28 (n = 98) 37 (n = 92) 0.09
Hospital admission in autumn/winter (Sept. 21st - March 21st) 68 (n = 100) 69 (n = 96) 0.55
Coronary artery disease discharge diagnosis 41 (n = 96) 46 (n = 94) 0.39
Heart failure discharge diagnosis 35 (n = 96) 28 (n = 94) 0.33
The number of observations is given between brackets. The table gives the P-values (of the Student’s t-tests or the Chi-squared test) that
result when testing for differences between the groups.
Active smoking gives the number of patients that were active smokers in the 3 months preceding the study.
The vast majority of patients were included in the study shortly after admission from home. The number of patients coming from intensive care
is expected to be very low; however, we did not record these data. Patients were bedridden, and in general had no surgery or anaesthesia
(post-operative patients in principle were admitted on a different ward). Moreover, we believe that the analysis sample represents the less ill
patient group. The study included a relatively large number of questionnaires, which is difﬁcult to comply with for very ill patients. Severely ill
patients were less likely to consent to the study.
Table 3 Mean subjective sleep scores and 95% conﬁdence interval (95% CI) within control and intervention patients at study intake and
hospital discharge, as evaluated by the Pittsburg Sleep Quality Index (PSQI) global score
Intake Discharge Delta = discharge  intake
Control Intervention Control Intervention Control Intervention
Subjects per group 44 48 37 43 37 43
Global PSQI 7.32 8.54 7.62 8.16 0.27 0.88
(95% CI) (5.93–8.71) (7.21–9.87) (6.34–8.9) (6.97–9.35) (1.00 to 1.54) (2.06 to 0.30)
The delta column gives the mean of the discharge  intake PSQI score of individual patients for both groups. The global PSQI score ranges
from 0 to 21, a lower score indicates a better sleep quality.
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analysis; for every single day that a patient stays in the
intervention room as compared to staying in the control room,
TSD increases by an extra 5.9 min per hospital day (P = 0.03).
When the regression analysis is restricted to the ﬁrst ﬁve
hospitalization days, TSD in intervention patients tends to
increase by an extra 14.5 min per day (P = 0.0503) as
compared to control patients. In the 5-day case, SOL in
intervention patients decreases by an extra 4.3 min per day
(P = 0.02) as compared to patients in the control group.
Figure 4 shows how the between-group differences as pre-
dicted by the Table 4 regression models develop over time.
There were no signiﬁcant interventional effects within the
actigraphic sleep efﬁciency regression coefﬁcients, neither
for the 20-day nor for the 5-day case (see Data S2).
Sleepiness and mood symptoms
There were no signiﬁcant interventional effects within the
regression coefﬁcients of the KSS and HADS data, neither
for the 20-day nor for the 5-day models. The data are
presented in the Data S2.
Headache and eye-strain
The HES questionnaire probes eight items, each on a
discrete four-point scale (0 = absent, 1 = slight, 2 = moder-
ate, 3 = severe). Four items had signiﬁcant interventional
effects in the 20-day and 5-day regression analyses. Table 5
shows the regression effect estimates for these four items. In
the 20-day analysis, the HES-items ‘eye-strain’ and ‘eye-
fatigue’ had a signiﬁcantly higher baseline score (i.e. more
symptoms) in intervention patients as compared with control
patients (the corresponding b2 and P-values are shown in
Table 5). Moreover, intervention patients developed slightly
more ‘difﬁculties concentrating’ over time than control
patients: in Table 5 the intervention 9 time effect was small
but signiﬁcant (b3 = 0.032; P = 0.034). In the 5-day model,
the interaction effect for ‘difﬁculties concentrating’ was no
Table 4 Effect estimates of the multilevel linear regression model (Eq. 1) for the actigraphic outcomes TSD and SOL as obtained for the
overall analysis (up to 20 days of hospitalization) and for the restricted analysis (up to the ﬁrst 5 days of hospitalization)
Overall analysis First 5 days analysis
TSD SOL TSD SOL
(95% CI) (95% CI) (95% CI) (95% CI)
Baseline control group (b0) 402.3 min 17.9 min 406.8 min 12.4 min
(375.6–428.9) (11.7–24.1) (367.6–446.0) (3.1–21.7)
Baseline intervention group (b0 + b2) 401.0 min 15.7 min 378.0 min 22.4 min
(374.7–427.4) (9.6–21.9) (338.5–417.6) (12.9–31.9)
Control group change over time (b1) 1.3 min day1 0.2 min day1 3.2 min day1 1.5 min day1
(5.2 to 2.5) (0.8 to 1.1) (13.5 to 7.0) (1.1 to 4.1)
Intervention group change over time (b1 + b3) 4.5 min day
1 0.7 min day1 11.3 min day1 2.8 min day1
(0.8–8.2) (1.6 to 0.3) (1.0–21.6) (5.4 to 0.2)
Intervention effect on baseline (b2) 1.2 min 2.1 min 28.8 min 10.0 min
(38.7 to 36.2) (10.8 to 6.6) (84.5 to 26.9) (3.3 to 23.3)
P = 0.948 P = 0.632 P = 0.311 P = 0.141
Intervention effect on change over time (b3) 5.9 min day
1 0.8 min day1 14.5 min day1 4.3 min day1
(0.6–11.2) (2.2 to 0.6) (0.0–29.1) (8.0 to 0.6)
P = 0.030* P = 0.240 P = 0.050 P = 0.022*
Intervention-control, 5th hospital night (b2 + 5b3) 28.2 min 6.2 min 43.9 min 11.6 min
(2.0 to 58.3) (12.6 to 0.1) (2.7–85.0) (20.8 to 2.3)
P = 0.067 P = 0.055 P = 0.037* P = 0.014*
Standard deviation of aj 57.5 10.9 58.5 10.2
Standard deviation of eij 70.9 18.9 70.4 18.3
The 95% conﬁdence interval (95% CI) is given in brackets. For the interventional effect estimates b2 and b3, the two-sided P-values are also
given, and an asterisk (*) denotes a signiﬁcant effect (P < 0.05).
The baseline value is the regression model estimation (Eq. 1) for the night before hospitalization (i.e. for HospitalDay = 0).
aj represents the patient-dependent (random) part of the intercept of Eq. (1), and eij represents the error term.
Note that the slope of the Eq. (1) regression model within control patients equals b1, and in intervention patients it equals b1 + b3. These
coefﬁcients are constant and do not vary among individual patients, only the intercept of the regression line depends on the individual patient.
After 5 nights of hospitalization, the TSD and SOL change with respect to baseline equals 5 * b1 for control patients, and 5 * b1 + 5 * b3 for
intervention patients, see Eq. (1). For this change the between-group difference hence equals 5 * b3. In the overall TSD case this
corresponds to 29 min.
After model adjustment, some of the patient characteristics from Table 2 inﬂuenced the coefﬁcients of the TSD and SOL regression models,
see Supporting Information Data S2. However, those characteristics did not have a signiﬁcant unbalance (P < 0.05) between the control and
intervention sample used. Therefore, the unadjusted basis model of Eq. (1) was used to estimate effect sizes.
SOL, sleep-onset latency; TSD, total sleep duration.
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Figure 3. The actigraphic total sleep duration (TSD, in min) data-points and the corresponding regression model lines (see Eq. 1 and Table 4)
of each individual patient j (denoted by the number above each panel), for the overall (20-day) analysis (black), and when restricting the analysis
to the data of the ﬁrst ﬁve hospitalization nights only (grey). Each panel represents a patient: (a) all control patients, CP (01-39); (b) all
intervention patients, IP (40–78).
ª 2016 The Authors. Journal of Sleep Research published by John Wiley & Sons Ltd on behalf of European Sleep Research Society.
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longer signiﬁcant (P = 0.56), but here intervention patients
had an extra increase over time as compared with control
patients for the items ‘headache’ and ‘eye-fatigue’, the extra
increases being 0.17 and 0.13 points per day, respectively.
Moreover, in the 5-day model, intervention patients had a
signiﬁcantly lower baseline score for ‘headache’ as compared
with control patients (b2 = 0.677; P = 0.008).
DISCUSSION
The overall (20-day) regression model for actigraphic sleep
showed a signiﬁcant TSD increase by 5.9 min per hospital-
ization day with the new lighting system instead of standard
lighting. In the 5-day regression, i.e. when only analysing
data of the ﬁrst ﬁve hospitalization nights, TSD increased by
14.5 min per intervention day with a P-value on the verge of
signiﬁcance. The conﬁdence intervals of the model param-
eters for both regressions are largely overlapping. In the 20-
day regression the standard error in b3 is smaller as
compared to the 5-day regression. This is likely due to the
larger range in the explanatory variable ‘HospitalDay’ for the
20-day regression. Non-linearity of the changes over time
can also contribute to the difference in b3 between the 5- and
20-day regression: in the early days of hospitalization, the
changes over time are expected to be larger as compared
with later days where effect sizes tend to saturate. Moreover,
patients with a shorter LOS might have better (health)
characteristics than patients with a longer LOS, with fewer
sleep-compromising medical factors, and a better ability to
respond to the intervention (at least initially). Hence, a higher
TSD increase per intervention day (b3) is expected for the
5-day regression than for the 20-day regression, as is indeed
observed. With the same argumentation a larger decrease in
SOL per intervention day is expected for the 5-day regression
than for the 20-day regression. For SOL the b3 value differed
signiﬁcantly from zero only in the 5-day regression. These
ﬁndings suggest that the new lighting system is supportive for
a shorter SOL. Moreover, the global PSQI score tended to
improve under the new lighting system. We were unable to
assess effects of the lighting intervention on daytime sleep,
as many patients did not wear the actiwatch during daytime.
Regular 24 h light/dark patterns with sufﬁcient daytime
brightness, and night-time darkness (or dim light), can help
health- and elderly-care residents to maintain their circadian
rhythm (Beauchemin and Hays, 1998; Campbell et al., 1986;
Morag and Ohlsson, 2013; Ritchie et al., 2015; White et al.,
2013; Wirz-Justice, 2007). Moreover, evening/night-time light
exposure acutely suppresses melatonin production. This
sleep-disruptive effect can be reduced by lowering light
intensity (Brainard et al., 2015; Santhi et al., 2011), or by
offering a preceding (daytime) exposure to bright light (Hebert
et al., 2002). Furthermore, 4 weeks of midday bright light are
known to increase nocturnal melatonin levels in elderly
insomniacs (Mishima et al., 2001). In white-collar ofﬁce
workers, the quality of subjective nocturnal sleep was found
to improve under a 4-week exposure to blue-enriched white
light during daytime workhours (Viola et al., 2008). As the
current lighting intervention combines a low evening/night-
time light exposure with two late-morning hours of bright,
blue-enriched light, similar effects and mechanisms could
contribute to the modest favourable inﬂuence of the current
lighting intervention on sleep duration during hospitalization.
Two large-scale investigations (Choi et al., 2012; Joarder
and Price, 2013) found an association between brighter
daytime light conditions and shorter LOS of patients. In our
study we found no difference in LOS between intervention and
control patients. Study participants had amean baseline sleep
durationof401.6 min,quitesimilar to the424.5 min reportedby
Redeker et al. (1998). An exploratory analysis within the
current population sample indicated that a longer baseline
sleep duration can act as a signiﬁcant predictor for a shorter
LOS (see Data S3).
Figure 4. Multilevel linear regression
predictions for the intervention–control
difference in total sleep duration (TSD) and
sleep-onset latency (SOL) across
hospitalization in the 20-day and 5-day
regression model. The model assumes that
this difference changes linearly over time by
b2 + HospitalDay * b3 (see Eq. 1 and
Table 4). The shaded region is the 95%
conﬁdence interval. The conﬁdence interval
of the difference no longer includes zero
after a few nights, only then the intervention
effect on the change over time (b3) starts to
dominate over the uncertainty in the
intervention effect on the baseline (b2).
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Multilevel linear regression models tend to overestimate
the signiﬁcance of effects on outcomes that are highly
discrete in nature, like the HES. Nonetheless, the ﬁndings
suggest that the intervention slightly affects some HES items.
More studies are needed to assess the inﬂuence of lighting
conditions on headache and eye-strain complaints in hospital
patients.
The HADS scores in this study were close to 5 (see Data
S2) and classiﬁed as ‘normal’, leaving little opportunity for
improvements. Additional studies need to clarify whether the
intervention can treat depressive patients.
Twolimitationsof thisstudyareworthnoting.During thestudy
the hospital changed from paper-based to electronic registra-
tionofmedicationprescriptions, andprescriptiondatacouldnot
be retrieved for nearly 20% of the patients. Prescription
evaluation classiﬁed patients as users or non-users for: (1)
aspirin/oral anti-coagulation; (2) anti-arrhythmic drugs; (3)
psychopharmaca; (4) AT2-antagonists; (5) calcium-antago-
nists; (6) diuretics; (7) nitrates; (8) ACE-inhibitors; (9) beta-
blocking agents. Hypnotics were used very restrictively. The
two intake groups in this study as shown in Table 2 only
differed signiﬁcantly for beta-blockers (P = 0.04), these were
used more frequently in intervention patients. Beta-blockers
are known to negatively impact sleep (Yamada et al., 1995)
and might affect the ability of a patient to respond to the
intervention. Sleep in patients on beta-blockers improves
under nightly melatonin administration (Scheer et al., 2012).
The lighting intervention could induce similar effects within
patients on beta-blockers (increasing their endogenous
night-time melatonin production). However, a beta-blocker-
adjusted analysis for TSD (20-day case) suggests that beta-
blocker users might be less responsive to the lighting
intervention than beta-blocker non-users (see Data S2). This
topic merits further study.
Patient inclusion in this study proceeded much slower than
expected, and time and budget restrictions enforced study
closure without reaching the targeted sample size. The
current analysis was based on a relatively modest and
incomplete dataset.
In summary, standardly-lit patient rooms did not differ in LOS
as compared to patient rooms with a dynamic lighting system
that provided bright daytime, and low nocturnal light exposure.
Table 5 Effect estimates of the linear multilevel regression model for the four HES items that had signiﬁcant interventional effects in the
20-day and 5-day analyses
Overall analysis
HES eye-strain HES eye-fatigue
HES difﬁculty
concentrating
HES
headache
(95% CI) (95% CI) (95% CI) (95% CI)
Baseline control
group (b0)
0.239 0.421 0.523 0.472
(0.060–0.418) (0.215–0.626) (0.332–0.714) (0.301–0.643)
Baseline intervention
group (b0 + b2)
0.528 0.757 0.522 0.389
(0.353–0.702) (0.557–0.957) (0.335–0.708) (0.222–0.556)
Control group change
over time (b1)
0.004 0.014 0.029 0.022
(0.013 to 0.022) (0.034 to 0.006) (0.050 to
0.008)
(0.042 to 0.002)
Intervention group
change over
time (b1 + b3)
0.010 0.018 0.003 0.009
(0.027 to 0.007) (0.038 to 0.002) (0.018 to 0.024) (0.028 to 0.011)
Intervention effect
on baseline (b2))
0.289 0.336 0.002 0.083
(0.038–0.539) (0.050–0.623) (0.268 to 0.265) (0.323 to 0.156)
P = 0.024* P = 0.022* P = 0.991 P = 0.494
Intervention effect
on change over
time (b3)
0.014 0.004 0.032 0.013
(0.039 to 0.010) (0.032 to 0.025) (0.002–0.062) (0.015 to 0.041)
P = 0.259 P = 0.785 P = 0.034* P = 0.367
Intervention-control,
5th hospital
night (b2 + 5b3)
0.218 0.317 0.159 0.019
(0.001 to 0.437) (0.067–0.567) (0.064 to 0.381) (0.213 to 0.175)
P = 0.051 P = 0.013* P = 0.163 P = 0.848
Standard deviation
of aj
0.514 0.584 0.507 0.435
Standard deviation
of eij
0.346 0.404 0.424 0.403
The 95% conﬁdence interval (95% CI) is given in brackets. For the interventional effect estimates (b2 and b3), two-sided P-values are
given below the 95% CI, an asterisk (*) denotes that the parameter differs signiﬁcantly (P < 0.05) from zero.
The HES questionnaire uses a discrete four-point scale (0 = absent, 1 = slight, 2 = moderate, 3 = severe) for eight items: irritability,
headache, eye-strain, general eye-discomfort, eye-fatigue, difﬁculty focusing, difﬁculty concentrating, and blurred vision.
The baseline value is the regression model estimation for the variable in the night before hospitalization (i.e. for HospitalDay = 0).
aj represents the patient-dependent (random) part of the intercept of Eq. (1), and eij represents the error term.
HES, Headache and Eye-Strain questionnaire.
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Also, subjective sleep (PSQI), and anxiety and depression
scores (HADS) were not different between the conditions. The
lighting intervention resulted in some improvements in objec-
tive (actigraphic) sleep and lighting appraisal within hospital-
ized patients.Concurrently, the subjective sleepof intervention
patients, as judged from the global PSQI scores, had a
tendency to improve during hospitalization. The application of
lighting conditions to shape healthcare facilities that support
health and wellbeing, both for patients and staff, merits further
research, thus developing lighting strategies that enable
hospital environments to become less disruptive for sleep,
mood and circadian rhythms.
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